These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19655109)

  • 1. Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease.
    Page AJ; Blackshaw LA
    Handb Exp Pharmacol; 2009; (194):227-57. PubMed ID: 19655109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease.
    Kessing BF; Conchillo JM; Bredenoord AJ; Smout AJ; Masclee AA
    Aliment Pharmacol Ther; 2011 Mar; 33(6):650-61. PubMed ID: 21219371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: the pathophysiology of gastro-oesophageal reflux disease.
    Boeckxstaens GE
    Aliment Pharmacol Ther; 2007 Jul; 26(2):149-60. PubMed ID: 17593062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gastro-oesophageal vagal afferents by galanin in mouse and ferret.
    Page AJ; Slattery JA; O'donnell TA; Cooper NJ; Young RL; Blackshaw LA
    J Physiol; 2005 Mar; 563(Pt 3):809-19. PubMed ID: 15637101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of gastro-oesophageal reflux and oesophagocardiac reflex in patients with angina-like chest pain following cardiologic investigations.
    Rosztóczy A; Vass A; Izbéki F; Nemes A; Rudas L; Csanády M; Lonovics J; Forster T; Wittmann T
    Int J Cardiol; 2007 May; 118(1):62-8. PubMed ID: 16891012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for gastro-oesophageal reflux disease.
    Wurm P; De Caestecker J
    Expert Opin Emerg Drugs; 2005 May; 10(2):457-71. PubMed ID: 15934879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of gastro-oesophageal reflux disease and novel options for its therapy.
    Dent J
    Neurogastroenterol Motil; 2008 May; 20 Suppl 1():91-102. PubMed ID: 18402646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transitory relaxation of the esophageal inferior sphincter and gastroesophageal reflux].
    Armenian B
    Rev Med Suisse Romande; 1997 Oct; 117(10):797-9. PubMed ID: 9441363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights in the neural regulation of the lower oesophageal sphincter.
    Blackshaw LA
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():33-9. PubMed ID: 18924442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease.
    Thoua NM; Khoo D; Kalantzis C; Emmanuel AV
    Aliment Pharmacol Ther; 2008 Mar; 27(5):396-403. PubMed ID: 18081729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of GORD. Emerging therapeutic targets and concepts.
    Zerbib F
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):937-46. PubMed ID: 21126705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characterization of vagal afferents relevant to mucosal nociception in the rat upper oesophagus.
    Lennerz JK; Dentsch C; Bernardini N; Hummel T; Neuhuber WL; Reeh PW
    J Physiol; 2007 Jul; 582(Pt 1):229-42. PubMed ID: 17478536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease: beyond mucosal injury.
    Shaker R
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2():S160-2. PubMed ID: 17575516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease.
    Vaezi MF
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():40-9. PubMed ID: 16483269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?
    Hirsch DP; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2002 Jan; 16(1):17-26. PubMed ID: 11856074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
    Kahrilas PJ; Boeckxstaens G
    Gut; 2012 Oct; 61(10):1501-9. PubMed ID: 22684485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lower oesophageal sphincter.
    Boeckxstaens GE
    Neurogastroenterol Motil; 2005 Jun; 17 Suppl 1():13-21. PubMed ID: 15836451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primperan and gastroesophageal reflux. Review of the literature].
    Albot G
    Ann Gastroenterol Hepatol (Paris); 1985 May; 21(2 Pt 2):17-20. PubMed ID: 3898989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.